Announcement
11 Feb 2021
In February 2021, the U.S. Administration signed a USD 1.750 billion contract with Moderna, Inc for the purchase of additional 100 million doses of COVID-19 vaccines.
Source
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
Implementation date
11 Feb 2021
Revocation date:
No revocation date
Announced: 15 Jun 2021
United States of America: Moderna is awarded $144.1 million in support of the COVID-19 vaccine development for pediatric population, aged between six months to 12 years old
Announced: 18 Apr 2021
United States of America: Moderna is awarded $236.4 million in support of the additional development of mRNA-1273 vaccine
Announced: 12 Mar 2021
United States of America: Moderna is awarded $62.7 million in support of the COVID-19 vaccine additional development
Announced: 11 Feb 2021
United States of America: U.S. Government purchases addition COVID-19 vaccine doses from Pfizer for $2 billion
Announced: 11 Dec 2020
United States of America: Moderna is awarded a $1.66 billion contract for the manufacture and delivery of additional COVID-19 vaccines doses
Announced: 08 Dec 2020
United States of America: Executive Order on Ensuring Access to United States Government COVID-19 Vaccines
Announced: 25 Jul 2020
United States of America: Moderna is awarded $472 million in support of the Phase 3 clinical trial of a COVID-19 vaccine
Announced: 24 May 2020
United States of America: Moderna is awarded $53 million in support of the COVID-19 vaccine manufacturing capacity expansion
Announced: 16 Apr 2020
United States of America: Moderna is awarded $430 million for the COVID-19 vaccine development process
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
71988
193
This Thread tracks export restrictions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers policy actions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant intervention types and HS codes. For intervention ty...
Published: 09 Jan 2025
670
98